Home   Chapter Home   Jobs   Conferences   Fellowships   Books

Advertisement

Chronic Myeloid Neoplasms

Reviewer: Nikhil Sangle, M.D. (see Reviewers page)
Revised: 22 August 2011, last major update August 2011
Copyright: (c) 2001-2011, PathologyOutlines.com, Inc.

Table of contents

Myelodysplastic syndromes (MDS): general,  WHO classification,  childhood,  refractory anemia,  refractory anemia with ringed sideroblasts,  refractory cytopenia with multilineage dysplasia,  refractory anemia with excess blasts,  5q-syndrome,  therapy related,  unclassified,  arsenic toxicity

Myeloproliferative neoplasms (MPN): general,  WHO classification,  chronic eosinophilic leukemia,  chronic myelogenous leukemia,  chronic neutrophilic leukemia,  essential thrombocythemia,  hypereosinophilic syndrome,  mast cell disease,  polycythemia vera,  primary myelofibrosis,  unclassifiable

MDS/MPN: general,  WHO classification,  atypical CML,  chronic myelomonocytic leukemia (CMML),  chronic myelomonocytic leukemia with eosinophilia,  juvenile myelomonocytic leukemia,  unclassifiable

Myeloid neoplasms associated with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1: PDGFRA,  PDGFRB,  FGFR1

Miscellaneous: transient myeloproliferative disorder of Down’s syndrome

Alphabetical table of contents

A-E: 5q-syndrome,  arsenic toxicity,  atypical CML,  childhood MDS,  chronic eosinophilic leukemia,  chronic myelogenous leukemia,  chronic myelomonocytic leukemia (CMML),  chronic myelomonocytic leukemia with eosinophilia,  chronic neutrophilic leukemia,  essential thrombocythemia

F-N: hypereosinophilic syndrome,  juvenile myelomonocytic leukemia,  mast cell disease,  MDS-general,  MDS/MPN general,  MPN-general,  myeloid neoplasms associated with eosinophilia and abnormalities of FGFR1,  myeloid neoplasms associated with eosinophilia and abnormalities of PDGFRA,  myeloid neoplasms associated with eosinophilia and abnormalities of PDGFRB

O-Z: polycythemia vera,  primary myelofibrosis,  refractory anemia,  refractory anemia with excess blasts,  refractory anemia with ringed sideroblasts,  refractory cytopenia with multilineage dysplasia,  therapy related MDS,  transient myeloproliferative disorder of Down’s syndrome,  unclassified MDS,  unclassifiable MDS/MPN,  unclassifiable MPN,  WHO classification of MDS,  WHO classification of MDS/MPN,  WHO classification of MPN

End of Chronic myeloid neoplasms chapter